Approval · Notice of Compliance 1638 · 1999
NU-CEFADROXIL: Notice of Compliance 1638
Issued July 26, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1638
- Date
- July 26, 1999
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- DURICEF (Bristol-Myers Squibb S.R.L.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-CEFADROXIL | 02240600 | Approved |
Medicinal ingredients
- CEFADROXIL 500 MG per CAP